Efficacy of Isoniazid Prophylaxis in Pediatric Patients at High Risk for LTBI Undergoing Hematopoietic Stem Cell Transplantation - Top-Institutions - MDSpire

Efficacy of Isoniazid Prophylaxis in Pediatric Patients at High Risk for LTBI Undergoing Hematopoietic Stem Cell Transplantation

  • By

  • Uet Yu

  • Jiaming Yu

  • Xindan Lian

  • Yu Liu

  • Xiaodong Wang

  • Qian Zhang

  • Chunjing Wang

  • Chunlan Yang

  • Yue Li

  • Xiaohui Zhou

  • Xiaoling Zhang

  • Sixi Liu

  • February 2, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Stem Cell Transplantation
    • Infectious Diseases
    • Pediatric Oncology
  • #2

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Transplant Infectious Disease
  • #3

    St. Jude Children’s Research Hospital
    St. Jude Children’s Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Infectious Diseases
    • Transplantation
  • #4

    Shanghai Children’s Medical Center
    Shanghai Children’s Medical Center

    Shanghai, China

    Key Differentiators

    • Pediatric Hematology
    • Infectious Diseases
    • Transplantation
  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Hematology-Oncology
    • Infectious Diseases
    • Transplant Medicine

Original Source(s)

Related Content